Kyndryl faces securities class action over financial reporting deficiencies

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Kyndryl Holdings faces securities lawsuit alleging false financial statements and inadequate internal controls, with shareholders from August 2024-February 2026 eligible to join the class action.

Kyndryl faces securities class action over financial reporting deficiencies

The Gross Law Firm has initiated a securities class action lawsuit against Kyndryl Holdings, Inc. (NYSE: KD), alleging the company made materially false and misleading statements regarding its financial condition and internal control mechanisms. The litigation encompasses the period from August 7, 2024 through February 9, 2026, during which the company allegedly failed to maintain adequate internal controls and was unable to file quarterly reports in a timely manner.

The lawsuit targets shareholders who invested in Kyndryl during the specified class period and seeks to hold the company accountable for alleged disclosure failures. According to the complaint, the company's financial statements did not accurately reflect its operational challenges, particularly regarding its ability to meet regulatory filing deadlines.

Shareholders who purchased Kyndryl stock during the class period have until April 13, 2026 to register their claims with The Gross Law Firm. The deadline represents a key date for investors seeking to participate in the legal action or explore their options regarding potential losses.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 18

Related Coverage

GlobeNewswire Inc.

Plug Power Faces Class Action Over DOE Loan Claims as April Deadline Looms

Plug Power faces class action lawsuit alleging false statements about DOE loans and hydrogen facilities. Investors have until April 3, 2026 to apply as lead plaintiffs.

PLUG
GlobeNewswire Inc.

BlackRock TCP Capital Hit by Class Action Over $19B NAV Collapse

BlackRock TCP Capital faces class action lawsuit after 19% NAV decline and 12.97% stock plunge. Investors must act by April 6 deadline.

TCPC
GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
GlobeNewswire Inc.

Class Action Lawsuit Filed Against China Liberal Education Over Alleged $300M Pump-and-Dump Scheme

Class action lawsuit filed against China Liberal Education Holdings for alleged pump-and-dump scheme coordinating with scammers, resulting in $300M+ investor losses.

CLEUF
GlobeNewswire Inc.

METC Faces Class Action Over Brook Mine Claims; Lead Plaintiff Deadline Set for March 31

Ramaco Resources faces class action lawsuit over alleged false Brook Mine operational claims, with lead plaintiff deadline set for March 31, 2026.

METCMETCBMETCI
GlobeNewswire Inc.

Disc Medicine Stock Collapses on FDA Rejection; Law Firm Probes Securities Fraud

Pomerantz LLP investigates Disc Medicine ($IRON) for potential securities fraud after FDA rejected bitopertin drug application, triggering consecutive stock declines totaling over 28%.

IRON